MDT

95.86

-0.14%↓

VEEV

289.87

+1.52%↑

A

145.91

+2.06%↑

HQY

95.86

+2.98%↑

TLRY

1.48

-5.73%↓

MDT

95.86

-0.14%↓

VEEV

289.87

+1.52%↑

A

145.91

+2.06%↑

HQY

95.86

+2.98%↑

TLRY

1.48

-5.73%↓

MDT

95.86

-0.14%↓

VEEV

289.87

+1.52%↑

A

145.91

+2.06%↑

HQY

95.86

+2.98%↑

TLRY

1.48

-5.73%↓

MDT

95.86

-0.14%↓

VEEV

289.87

+1.52%↑

A

145.91

+2.06%↑

HQY

95.86

+2.98%↑

TLRY

1.48

-5.73%↓

MDT

95.86

-0.14%↓

VEEV

289.87

+1.52%↑

A

145.91

+2.06%↑

HQY

95.86

+2.98%↑

TLRY

1.48

-5.73%↓

Search

Viatris Inc

Chiusa

SettoreSettore sanitario

10.39 1.17

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

10.3

Massimo

10.43

Metriche Chiave

By Trading Economics

Entrata

3B

-4.6M

Vendite

328M

3.6B

Rendimento da dividendi

4.93

Margine di Profitto

-0.128

Dipendenti

32,000

EBITDA

2.9B

578M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+13.08% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

4.93%

3.00%

Utili prossimi

6 nov 2025

Prossima data del Dividendo

12 dic 2025

Prossima data del' Ex Dividendo

21 nov 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

1B

11B

Apertura precedente

9.22

Chiusura precedente

10.39

Punteggio Tecnico

By Trading Central

Fiducia

Bullish Evidence

Viatris Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

9 ott 2025, 09:10 UTC

Azioni calde

Stocks to Watch Thursday: HSBC, PepsiCo, MP Materials -- WSJ

Confronto tra pari

Modifica del prezzo

Viatris Inc Previsione

Obiettivo di Prezzo

By TipRanks

13.08% in crescita

Previsioni per 12 mesi

Media 11.5 USD  13.08%

Alto 15 USD

Basso 8 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Viatris Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

4 ratings

1

Acquista

2

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

8.48 / N/ASupporto e resistenza

A breve termine

Bullish Evidence

A termine intermedio

Very Strong Bullish Evidence

A lungo termine

Strong Bearish Evidence

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Viatris Inc

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
help-icon Live chat